1. Louis JM, Bewley CA, Gustchina E, Aniana A, Marius Clore G Characterization and HIV-1 Fusion Inhibitory Properties of Monoclonal Fabs Obtained From a Human Non-immune Phage Library Selected Against Diverse Epitopes of the Ectodomain of HIV-1 gp41. J Mol Biol (353): 945-51, 2005. [Full Text/Abstract]
2. Williams DC Jr, Lee JY, Cai M, Bewley CA, Clore GM Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside. J Biol Chem (280): 29269-76, 2005. [Full Text/Abstract]
3. Bewley CA, Ray S, Cohen F, Collins SK, Overman LE Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues. J Nat Prod (67): 1319-24, 2004. [Full Text/Abstract]
4. Bewley CA, Cai M, Ray S, Ghirlando R, Yamaguchi M, Muramoto K New carbohydrate specificity and HIV-1 fusion blocking activity of the cyanobacterial protein MVL: NMR, ITC and sedimentation equilibrium studies. J Mol Biol (339): 901-14, 2004. [Full Text/Abstract]
5. Fetterolf B, Bewley CA Synthesis of a bromotyrosine-derived natural product inhibitor of mycothiol-S-conjugate amidase. Bioorg Med Chem Lett (14): 3785-8, 2004. [Full Text/Abstract]
6. Louis JM Nesheiwat I Chang L Clore GM Bewley CA Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion. J Biol Chem (278): 20278-85, 2003. [Full Text/Abstract]
7. Chang L, Whittaker NF, Bewley CA Crambescidin 826 and dehydrocrambine A: new polycyclic guanidine alkaloids from the marine sponge Monanchora sp. that inhibit HIV-1 fusion. J Nat Prod (66): 1490-4, 2003. [Full Text/Abstract]
8. Nicholas GM Eckman LL Newton GL Fahey RC Ray S Bewley CA Inhibition and kinetics of mycobacterium tuberculosis and mycobacterium smegmatis mycothiol-S-conjugate amidase by natural product inhibitors. Bioorg Med Chem (11): 601-8, 2003. [Full Text/Abstract]
9. Bewley CA Louis JM Ghirlando R Clore GM Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J Biol Chem (277): 14238-45, 2002. [Full Text/Abstract]
10. Kelley BS Chang LC Bewley CA Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity. J Am Chem Soc (124): 3210-1, 2002. [Full Text/Abstract]
11. Knapp S Gonzalez S Myers DS Eckman LL Bewley CA Shortcut to mycothiol analogues. Org Lett (4): 4337-9, 2002. [Full Text/Abstract]
12. Bewley CA Kiyonaka S Hamachi I Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9). J Mol Biol (322): 881-9, 2002. [Full Text/Abstract]
13. Nicholas GM Kovac P Bewley CA Total synthesis and proof of structure of mycothiol bimane. J Am Chem Soc (124): 3492-3, 2002. [Full Text/Abstract]
14. Nicholas GM Newton GL Fahey RC Bewley CA Novel bromotyrosine alkaloids: inhibitors of mycothiol S-conjugate amidase. Org Lett (3): 1543-5, 2001. [Full Text/Abstract]
15. Bewley CA Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120. Structure (Camb) (9): 931-40, 2001. [Full Text/Abstract]
16. Bewley CA Otero-Quintero S The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. J Am Chem Soc (123): 3892-902, 2001. [Full Text/Abstract]